Effects of 17β-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-β1 and insulin-like growth factor-1 in primary human osteoblast cultures

Journal of Endocrinological Investigation

Volumn 27, Issue 10, 2004, Pages 904-912

  Mendez Davila C ^a   Garcia Moreno C ^a   Turbi C ^b   de la Piedra, C ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Medical Department   (Spain)

Author keywords

Estradiol; Insulin like growth factor 1; Interleukin 6; Selective estrogen receptor modulators; Transforming growth factor beta 1

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ESTRADIOL; INTERLEUKIN 6; MESSENGER RNA; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE METABOLISM; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; OSTEOBLAST; POSTMENOPAUSE; PROTEIN EXPRESSION; TRABECULAR BONE; AGED; BIOSYNTHESIS; CULTURE TECHNIQUE; FEMALE; MIDDLE AGED; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CELL CULTURE TECHNIQUES; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MIDDLE AGED; OSTEOBLASTS; OSTEOPOROSIS; POSTMENOPAUSE; RALOXIFENE; RNA, MESSENGER; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 12344314494     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347531     Document Type: Article

References (52)

1. Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 1994, 55: 273-86.
2. Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998, 13: 763-73.
3. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 1999, 13: 819-28.
4. Walsh CA, Birch MA, Fraser WD, Ginty AF, Gallagher JA. Cytokine expression by cultured osteoblasts from patients with osteoporotic fractures. Int J Exp Pathol 2000, 81: 159-63.
5. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996, 11: 1043-51.
6. Kveiborg M, Flyvbjerg A, Eriksen EF, Kassem M. Transforming growth factor-β1 stimulates the production of insulin-like growth factor-I and insulin growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 2001, 169: 549-61.
7. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995, 332: 305-31.
8. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992, 257: 88-91.
9. Keller ET, Binkley NC, Stebler BA, et al. Ovariectomy does not induce osteopenia through interleukin-6 in Rhesus monkey (Macaca Mulata). Bone 2000, 26: 55-62.
10. Kimble RB, Bain S, Pacifici R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 1997, 12: 935-41.
11. Rickard D, Russell G, Gowen M. Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteoporos Int 1992, 2: 94-102.
12. Chaudhary LR, Spelsberg TC, Riggs BL. Production of various cytokines by normal human osteoblast-like cells in response to IL-1beta and tumour necrosis factor-alpha: Lack of regulation by 17beta-estradiol. Endocrinology 1992, 130: 2528-34.
13. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell 1998; 9: 1903-18.
14. Hock JM, Canalis E, Centrella M. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvaria. Endocrinology 1990, 126: 421-6.
15. Bonewald LF, Mundy GR. Role of transforming growth factor-beta in bone remodeling. Clin Orthop 1990, 250: 261-76.
16. Schmidmaier G, Wildemann B, Lubberstedt M, Haas NP, Raschke M. IGF-I and TGF-beta 1 incorporated in a poly (D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture. J Biomed Mater Res 2003, 65:157-62.
17. Pfeilschifter JP, Seyedin S, Mundy GR. Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures. J Clin Invest 1998, 82: 680-5.
18. Dieudonné SC, Foo P, Van Zoelen EJJ, Burger EH. Inhibiting and stimulating effects of TGF-β1 on osteoclasic bone resorption in fetal mouse bone organ cultures. J Bone Miner Res 1991, 6: 479-87.
19. Marceli C, Yates AJ, Mundy GR. In vivo effects of human recombinant transforming growth factor-beta on bone turnover in normal mice. J Bone Miner Res 1991, 5: 1087-96.
20. Chenu C, Pfeilschifter JP, Mundy GR, Roodman GD. Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci USA 1988, 85: 5683-7.
21. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 1998, 13: 793-802.
22. Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effect on bone matrix formation and cell replication. Endocrinology 1988, 122: 254-60.
23. Wergedal JE, Mohan S, Lundy M, Baylink DJ. Skeletal growth factor and other factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 1990, 5: 179-86.
24. Torricelli P, Fini M, Giavaresi G, Giardino R. Osteoblasts cultured from osteoporotic bone: a comparative investigation on human and animal-derived cells. Artif Cells Blood Substit Immobil Biotechnol 2003, 31: 263-77.
25. Waters KM, Rickard DJ, Riggs BL, et al. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem 2001, 83: 448-62.
26. Nasu M, Sugimoto T, Kaji H, Chihara K. Estrogen modulates osteoblast proliferation and function regulated by parathyroid hormone in osteoblastic SaOS-2 cells: role of insulin growth factor (IGF-I) and IGF-binding protein-5. J Endocrinol 2000, 167: 305-13.
27. Draper MW. The role of selective estrogen receptor modulators (SERMs) in postmenopausal health. Ann N Y Acad Sci 2003, 997: 373-7.
28. Marie PJ, Lomri A, Sabbagh A, Basle M. Culture and behaviour of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell Dev Biol 1989, 25: 373-80.
29. Nacher M, Aubia J, Bosh J, Mariñoso ML, Hernández J, Serrano S. Caracterización de cultivos cle osteoblastos humanos. Revista Española de Enfermedades Metabólicas Óseas 1993, 2: 15-20.
30. Sur P, Sribnick EA, Wingrave JM, Nowak MW, Ray SK, Banik NL. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res 2003, 971: 178-88.
31. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72: 248-54.
32. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156-9.
33. Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA, Riggs BL. Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int 1998, 62: 60-6.
34. Sasse T, Becker P, Dorfling P, Schur T, Brock J. TGFβ-1 mRNA expression and proliferation of human osteoblastic cells in nonosteoporotic and osteoporotic women under influence of TGFβ-1 and IGF-I. Calcif Tissue Int 1998, 62: 60-6.
35. De Miguel, Martínez Fernández P, Guillén C, et al. Parathyroid hormone-related protein (107-139) stimulates interleukin-6 expression in human osteoblastic cells. J Am Soc Nephrol 1999, 10: 769-83.
36. Garcia-Ocaña A, Gomez-Casero E, Peñaranda C, Sarasa JL, Esbrit P. Cyclosporine increases renal parathyroid hormone-related protein expression in vivo in the rat. Transplantation 1998, 65: 860-3.
37. Kurihara N, Bertolini D, Suda T, Akijama Y, Roodman GD. Interlukin-6 stimulates osteoclast-like multinucleated cell formation in long-term human marrow cultures by inducing IL-1 release. J Immunol 1990, 144: 426-30.
38. Reddy SV, Takahashi S, Dallas M, Willians RE, Neckers L, Roodman RD. Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J Bone Miner Res 1994, 9: 753-7.
39. Kassem M. Cellular and molecular effects of growth hormone and estrogen on human bone cells. APMIS 1997, 105 (Suppl 71): 1-30.
40. Ireland DC, Bord S, Beavan SR, Compston JE. Effects of estrogen on collagen synthesis by cultured human osteoblasts depend on the rate of cellular differentiation. J Cell Biochem 2002, 86: 251-7.
41. Hierl T, Borcsök U, Sommer R, Ziegler C, Kasperk C. Regulation of interleukin-6 expression in human osteoblastic cells in vitro. Exp Clin Endocrinol Diabetes 1998, 106: 324-33.
42. Harris SA, Tau KR, Enger RJ, Toft DO, Riggs BL, Spelsberg TC. Estrogen response in the hFOB1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene. J Cell Biochem 1995, 59: 193-201.
43. Kassem M, Harris SA, Spelsberg TC, Riggs BL. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line expressing high levels of estrogen receptors. J Bone Miner Res 1996, 11: 193-9.
44. Dovio A, Sartori ML, Masera RG, Racca S, Angeli A. Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive Il-6 expression. Cytokine 2001, 15: 47-52.
45. Tsai JA, Rong H, Torring O, Matsushita H, Bucht E. Interleukin-1beta upregulates PTHrP-mRNA expression and protein production and decreases TGF-β in normal human osteoblast-like cells. Calcif Tissue Int 2000, 66: 363-9.
46. Yang NN, Bryant HU, Hardikar S, et al. Estrogen and raloxifene stimulate transforming growth factor-beta3 gene expression in rat bone: a potential mechanism for estrogenor raloxifene-mediated bone maintenance. Endocrinology 1996, 137: 2075-84.
47. Oursler MJ, Cortese C, Keeting P, et al. Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17beta-estradiol and parathyroid hormone. Endocrinology 1991, 129: 3313-20.
48. Ernst M, Rodan GA. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. Mol Endocrinol 1991, 5: 1081-9.
49. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler RC. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Intern Med 1993, 234: 249-55.
50. Thrailkill KM, Siddhanti SR, Fourlkes JL, Quarles LDC. Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs. Bone 1995, 17: 307-13.
51. Rosen CJ, Donaline LR, Hunter SJ. Insulin-like growth factors and bone: the osteoporosis connection. Proc Soc Exp Biol Med 1994, 206: 83-102.
52. Kveiborg M, Flyvbjerg A, Rattan SIS, Kassem M. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast function. Exp Gerontol 2000, 35: 1061-74.